Stock ABUS ARBUTUS BIOPHARMA CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Arbutus Biopharma Corporation

Equities

ABUS

CA03879J1003

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-31 pm EDT 		5-day change 1st Jan Change
3.36 USD +1.20% Intraday chart for Arbutus Biopharma Corporation +2.13% +34.40%
May. 20 Whitefort Capital Management Sends an Open Letter to Shareholders of Arbutus Biopharma CI
May. 17 Sector Update: Health Care Stocks Mixed Late Afternoon MT

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Arbutus to Participate in Jefferies Global Healthcare Conference
GL
Arbutus to Present Imdusiran Data at EASL Congress 2024
AQ
Arbutus to Present Imdusiran Data at EASL Congress 2024
GL
Whitefort Capital Publishes Open Letter to Arbutus Biopharma Shareholders Outlining Paths to Maximize Value
AQ
Whitefort Capital Publishes Open Letter to Arbutus Biopharma Shareholders Outlining Paths to Maximize Value
BU
Arbutus to Participate in Two Upcoming Investor Conferences
GL
Arbutus Biopharma : Corporate Presentation - May 2024
PU
Arbutus: Q1 Earnings Snapshot
AQ
Arbutus Reports First Quarter 2024 Financial Results and Provides Corporate Update
GL
Arbutus Announces Retirement of Chief Scientific Officer, Michael J. Sofia, PhD, Effective December 31, 2024
GL
Arbutus to Report First Quarter 2024 Financial Results and Provide Corporate Update
GL
Arbutus Biopharma : Corporate Presentation - April 2024
PU
Arbutus Biopharma Announces Claim Construction Ruling in its Ongoing Patent Infringement Lawsuit Against Moderna
GL
Arbutus to Participate in Two Upcoming Investor Conferences
GL
Arbutus to Participate in Two Upcoming Investor Conferences
AQ
Arbutus Biopharma Reports Fourth Quarter and Year End 2023 Financial Results and Provides Corporate Update
AQ
Arbutus Reports Fourth Quarter and Year End 2023 Financial Results and Provides Corporate Update
GL
Arbutus Reports Fourth Quarter and Year End 2023 Financial Results and Provides Corporate Update
AQ
Arbutus to Report Fourth Quarter and Year End 2023 Financial Results and Provide Corporate Update
GL
Arbutus Announces 2024 Corporate Objectives and Provides Financial Update
GL
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ABUS Stock
  4. News Arbutus Biopharma Corporation
  5. Press Releases